The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of nab-paclitaxel/bevacizumab (AB160) nano-immunoconjugate therapy for metastatic gynecological malignancies: MC1371 (NCT02020707).
 
Eleftheria Kalogera
No Relationships to Disclose
 
Vera Jean Suman
Patents, Royalties, Other Intellectual Property - US Patent #10,220,016 B2 issued 3/5/2019 Methods and materials for assessing chemotherapy responsiveness and treatment cancer Applicant Mayo Foundation One of the inventors: Vera Suman (Inst)
 
Wendy Kay Nevala
No Relationships to Disclose
 
Heidi Diann Finnes
No Relationships to Disclose
 
Jill Schimke
No Relationships to Disclose
 
Carrie Strand
No Relationships to Disclose
 
Gretchen Glaser
No Relationships to Disclose
 
Megan Grudem
No Relationships to Disclose
 
Aminah Jatoi
Research Funding - AstraZeneca (Inst)
 
Carolyn Klampe
No Relationships to Disclose
 
Amanika Kumar
No Relationships to Disclose
 
Carrie L Langstraat
Other Relationship - ConMed; Covidien/Medtronic; Covidien/Medtronic; Eight Medical
 
Andrea Elisabeth Wahner Hendrickson
No Relationships to Disclose
 
Saravut John Weroha
No Relationships to Disclose
 
Joel M. Reid
No Relationships to Disclose
 
Svetomir Markovic
Research Funding - Bristol-Myers Squibb; Seagen; Vavotar Life Sciences
 
Matthew Stephen Block
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Immune Design; Marker, Inc.; Merck; Pharmacyclics